Clinical Trials in Denver

Showing 10201-10220 of 18,161 trials

Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities

NCT02217501

The purpose of this study is to evaluate whether clopidogrel 75 mg daily on a background of aspirin 75-100 mg/d for clinically indicated duration or for an additional 12 months will lead to an increased rate of primary patency, limb salvage, non-fatal myocardial infarction (MI), ischemic stroke, and survival, in patients receiving endovascular treatment of PAD at end of study treatment.

Peripheral Arterial Disease

University of Texas Southwestern Medical Center159 participantsStarted Nov 2015

Denver, Colorado, United States • Davenport, Iowa, United States • Dallas, Texas, United States +1 more locations

COMPLETEDPhase 3< 1 mile

A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain

NCT00662558

To compare the analgesic effectiveness of celecoxib and tramadol in subjects with Chronic Low Back Pain measured by the Numerical Rating Scale (NRS-Pain) at Week 6

Low Back Pain

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.802 participantsStarted Jan 2008

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +57 more locations

Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities

A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain

Find Trials by Condition in Denver

Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple Sclerosis

Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris

Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1%

The Effect of PPI Therapy on Weight, Gut Microbiome, and Expression of GPR41 and GPR43

MEK162 for Patients With RAS/RAF/MEK Activated Tumors

A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma

Phase 3 Papulopustular Rosacea Study

To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients.

Trial In Pediatric Patients With Familial Adenomatous Polyposis (FAP)

Epiduo Pediatric Acne Study

MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.

Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents

Atorvastatin Three Year Pediatric Study

A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders

Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)

Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients

Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)

Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcinoma